Literature DB >> 10155269

Issues in the conduct of economic evaluations of pharmaceutical products.

M F Drummond.   

Abstract

Mesh：

Year:  1994        PMID： 10155269     DOI： 10.2165/00019053-199406050-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  11 in total

1.  Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status?

Authors:  M Drummond
Journal:  Health Econ       Date:  1992-07       Impact factor: 3.046

2.  Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

Authors:  I S Udvarhelyi; G A Colditz; A Rai; A M Epstein
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

3.  Economic analysis in randomized control trials.

Authors:  M E Adams; N T McCall; D T Gray; M J Orza; T C Chalmers
Journal:  Med Care       Date:  1992-03       Impact factor: 2.983

4.  Regulation of the pharmaceutical industry and now pharmacoeconomic research?

Authors:  N E Wells
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

5.  Economic evaluation of pharmaceuticals: science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

6.  Economic evaluation of pharmaceuticals: a critical appraisal of seven studies on cholesterol-lowering agents.

Authors:  P Gazzaniga; L Garattini
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

7.  Farewell to promoting goodbuys?

Authors: 
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

8.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

Authors:  A L Hillman; J M Eisenberg; M V Pauly; B S Bloom; H Glick; B Kinosian; J S Schwartz
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

9.  Conflict of interest. International Committee of Medical Journal Writers.

Authors: 
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

Review 10.  Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.

Authors:  A Briggs; M Sculpher; M Buxton
Journal:  Health Econ       Date:  1994 Mar-Apr       Impact factor: 3.046
View more
  1 in total

1.  Guidelines for pharmacoeconomic studies. The ways forward.

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.